TYK Medicines, Inc
TYK Medicines, Inc
Explore linked clinical trials.9 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases | Brain Metastases, Neoplasms by Site, brain disorder, central nervous system cancer, central nervous system disorder, neoplasm, nervous system disorder, non-small cell lung carcinoma | Recruiting | Phase 2 | 2026-08-25 | NCT05948813 | |
| Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors | Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, adenoma, epithelial neoplasm, lung disorder, lung neoplasm, malignant mesothelioma, mesothelial neoplasm, mesothelioma, neoplasm, pleural neoplasm, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Phase 1 / Phase 2 | 2025-12-22 | NCT07282873 | |
| Study of TYK-00540 Combined With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC） | mCRPC | Not yet recruiting | Phase 1 / Phase 2 | 2025-08-05 | NCT07104643 | |
| Study of TY-302 Capsules Combined With Abiraterone in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC） | Metastatic Castration-resistant Prostate Cancer (mCRPC) | Not yet recruiting | Phase 1 / Phase 2 | 2025-08-05 | NCT07104617 | |
| Study of TYK-00540 Tablets in Patients With Advanced Solid Tumors | HR-positive, HER2-negative Advanced Breast Cancer | Recruiting | Phase 1 / Phase 2 | 2025-04-29 | NCT06950086 | |
| A Study of TY-9591 With Chemotherapy as 1st Line Treatment in Patients With Mutated Epidermal Growth Factor Receptor NSCLC | non-small cell lung carcinoma | Not yet recruiting | Phase 2 | 2024-12-30 | NCT06672068 | |
| A Study of TYK-00540 in Adult Patients With Solid Tumors | Locally Advanced or Metastatic Solid Tumors | Recruiting | Phase 1 | 2024-02-07 | NCT06246071 | |
| Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO) | non-small cell lung carcinoma | Recruiting | Phase 3 | 2024-01-30 | NCT05382728 | |
| A Study of TY-2699a in Patients With Locally Advanced or Metastatic Solid Tumors | Solid Tumor, Adult | Recruiting | Phase 1 | 2023-11-07 | NCT05866692 |